← Back to the feed

Adualys Therapeutics AG

History from 18 Nov 2025

UID

CHE-139.199.367

Legal form

AG

Canton

BS

Founded

18 Nov 2025

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 21 Nov 2025 · legal date 18 Nov 2025

   Company formed

   Founded 18 Nov 2025

   SHAB HR01-1006491260 ↗

2. SHAB published 21 Nov 2025 · legal date 18 Nov 2025

   Capital band adopted

   SHAB HR01-1006491260 ↗

3. SHAB published 8 Apr 2026 · legal date 30 Mar 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   100’000 → 125’811.78

   Shares

   10’000’000 → 12’581’178

   New shares, % of post-step shares

   20.5% (2’581’178 new)

   Aktienkapital neu: CHF 125'811.78 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 125'811.78 [bisher: CHF 100'000.00]. Aktien neu: 12'581'178 Namenaktien zu CHF 0.01 [bisher: 10'000'000 Namenaktien zu CHF 0.01]. [gestrichen: Kapitalband gemäss näherer Umschreibung in den Statuten.]

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006618644 ↗

4. SHAB published 8 Apr 2026 · legal date 30 Mar 2026

   Capital band adopted

   SHAB HR02-1006618644 ↗

Published by 8 Oct 2026